Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 Feb;71(2):241–246.

Measurement of gamma-interferon in culture supernatants of antigen-stimulated lymphocytes from patients with Schistosoma mansoni infections by a reverse passive haemagglutination assay.

A E Butterworth 1, A Wilson 1, B A Richardson 1, J Harris 1, R K Gachuhi 1, D Senior 1, R R Coombs 1
PMCID: PMC1541446  PMID: 3127091

Abstract

An assay for gamma-interferon (IFN gamma) in human lymphocyte culture supernatants, based on reverse passive haemagglutination (RPH) of red cells bearing a monoclonal anti-IFN gamma antibody, was developed and compared with a conventional virus inhibition assay. Test samples comprised supernatants of lymphocytes from patients with Schistosoma mansoni infections, cultured with or without a soluble worm antigen preparation. The two assays gave comparable results, the correlations for individual samples being good. The RPH assay was both specific and sensitive, allowing the detection of IFN gamma at 13 u/ml (1 ng/ml) or less. The advantages of the RPH assay were that it was quick, relatively inexpensive and suitable for testing large numbers of samples. In particular, between-experiment variation was very low, allowing the assay of different samples on different occasions.

Full text

PDF
241

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkins G. J., Johnston M. D., Westmacott L. M., Burke D. C. Department of Biological Sciences, University of Warwick, Coventry, CV47AL, England. J Gen Virol. 1974 Dec;25(3):381–390. doi: 10.1099/0022-1317-25-3-381. [DOI] [PubMed] [Google Scholar]
  2. Butterworth A. E., Capron M., Cordingley J. S., Dalton P. R., Dunne D. W., Kariuki H. C., Kimani G., Koech D., Mugambi M., Ouma J. H. Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. Trans R Soc Trop Med Hyg. 1985;79(3):393–408. doi: 10.1016/0035-9203(85)90391-8. [DOI] [PubMed] [Google Scholar]
  3. Butterworth A. E., Dalton P. R., Dunne D. W., Mugambi M., Ouma J. H., Richardson B. A., Siongok T. K., Sturrock R. F. Immunity after treatment of human schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment. Trans R Soc Trop Med Hyg. 1984;78(1):108–123. doi: 10.1016/0035-9203(84)90190-1. [DOI] [PubMed] [Google Scholar]
  4. Chang T. W., McKinney S., Liu V., Kung P. C., Vilcek J., Le J. Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon. Proc Natl Acad Sci U S A. 1984 Aug;81(16):5219–5222. doi: 10.1073/pnas.81.16.5219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Coombs R. R. Harnessing the red cell for immunoassays. Med Lab Sci. 1987 Jan;44(1):66–72. [PubMed] [Google Scholar]
  6. Coombs R. R., Scott M. L., Cranage M. P. Assays using red cell-labelled antibodies. J Immunol Methods. 1987 Jul 16;101(1):1–14. doi: 10.1016/0022-1759(87)90209-2. [DOI] [PubMed] [Google Scholar]
  7. James S. L. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. III. Correlation of resistance with induction of activated larvacidal macrophages. J Immunol. 1986 May 15;136(10):3872–3877. [PubMed] [Google Scholar]
  8. Talmadge K. W., Gallati H., Sinigaglia F., Walz A., Garotta G. Identity between human interferon-gamma and "macrophage-activating factor" produced by human T lymphocytes. Eur J Immunol. 1986 Dec;16(12):1471–1477. doi: 10.1002/eji.1830161202. [DOI] [PubMed] [Google Scholar]
  9. Wilson A. B., Harris J. M., Waldmann H., Coombs R. R. Direct antibody rosette-forming reactions using monoclonal markers of lymphocyte subpopulations. Methodology and applications illustrated by investigations with rat pan-T antibodies of the CAMPATH series. J Immunol Methods. 1986 Sep 27;92(2):241–249. doi: 10.1016/0022-1759(86)90172-9. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES